AGEN – Agenus Inc.

Agenus Inc.

AGEN

$5.94

Name : Agenus Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $162,855,792.00

EPSttm : 29.61

Agenus Inc.

$5.94

15.12%

$0.78

Float Short %

15.47

Margin Of Safety %

Put/Call OI Ratio

0.37

EPS Next Q Diff

0.62

EPS Last/This Y

10.37

EPS This/Next Y

-2.53

Price

5.16

Target Price

11.5

Analyst Recom

2.2

Performance Q

119.57

Relative Volume

1.48

Beta

1.42

Ticker: AGEN

21 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-05-07	AGEN	2.95	0.07	0.02	10536
2025-05-08	AGEN	3.03	0.07	0.04	10541
2025-05-09	AGEN	2.91	0.06	0.00	10994
2025-05-12	AGEN	3.49	0.05	0.04	14504
2025-05-13	AGEN	3.37	0.06	0.41	13697
2025-05-14	AGEN	3.49	0.06	0.00	13472
2025-05-15	AGEN	3.37	0.06	0.02	14820
2025-05-16	AGEN	3.5	0.06	0.02	15019
2025-05-19	AGEN	3.79	0.05	0.02	8232
2025-05-20	AGEN	3.84	0.04	2.23	10204
2025-05-21	AGEN	3.65	0.07	0.23	10554
2025-05-22	AGEN	3.78	0.07	0.40	10703
2025-05-23	AGEN	3.83	0.08	0.06	10959
2025-05-27	AGEN	3.55	0.08	12.62	10988
2025-05-28	AGEN	3.01	0.16	0.02	11815
2025-05-29	AGEN	3.19	0.16	0.03	11975
2025-05-30	AGEN	3.43	0.14	0.49	13405
2025-06-02	AGEN	4.12	0.16	0.44	14040
2025-06-03	AGEN	5	0.17	0.03	14575
2025-06-04	AGEN	5.6	0.17	0.84	15638
2025-06-05	AGEN	5.17	0.37	0.63	20084
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

21 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-05-07	AGEN	2.95	34.9	123.8	-5.59
2025-05-08	AGEN	3.02	34.9	124.0	-5.59
2025-05-09	AGEN	2.91	34.9	123.6	-5.59
2025-05-12	AGEN	3.50	34.9	125.0	-5.59
2025-05-13	AGEN	3.39	34.9	123.7	-5.59
2025-05-14	AGEN	3.49	34.9	124.0	-5.59
2025-05-15	AGEN	3.37	34.9	110.4	-5.59
2025-05-16	AGEN	3.50	34.9	89.9	-5.59
2025-05-19	AGEN	3.79	71.0	89.7	-0.22
2025-05-20	AGEN	3.84	71.0	89.9	-0.22
2025-05-21	AGEN	3.64	71.0	90.1	-0.22
2025-05-22	AGEN	3.79	71.0	89.9	-0.22
2025-05-23	AGEN	3.83	71.0	89.9	-0.22
2025-05-27	AGEN	3.55	71.0	90.1	-0.22
2025-05-28	AGEN	3.02	71.0	90.3	-0.22
2025-05-29	AGEN	3.20	71.0	89.8	-0.22
2025-05-30	AGEN	3.43	71.0	89.8	-0.22
2025-06-02	AGEN	4.11	71.0	89.5	-0.22
2025-06-03	AGEN	5.00	71.0	89.4	-0.22
2025-06-04	AGEN	5.60	71.0	89.6	-0.22
2025-06-05	AGEN	5.16	71.0	90.2	-0.22
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-05-07	AGEN	0.00	-6.11	20.05
2025-05-08	AGEN	0.00	-6.11	20.05
2025-05-09	AGEN	0.00	-6.11	20.05
2025-05-12	AGEN	0.00	-5.82	19.67
2025-05-13	AGEN	0.00	-5.82	19.67
2025-05-14	AGEN	0.00	-5.82	15.33
2025-05-15	AGEN	0.00	-5.82	15.19
2025-05-16	AGEN	0.00	-5.82	15.19
2025-05-19	AGEN	0.00	-6.22	15.37
2025-05-20	AGEN	0.00	-6.22	15.37
2025-05-21	AGEN	0.00	-6.22	15.37
2025-05-22	AGEN	0.00	-6.22	15.37
2025-05-23	AGEN	0.00	-6.22	15.37
2025-05-27	AGEN	0.00	11.59	15.37
2025-05-28	AGEN	0.00	11.59	15.47
2025-05-29	AGEN	0.00	11.59	15.47
2025-05-30	AGEN	0.00	11.59	15.47
2025-06-02	AGEN	0.00	12.46	15.47
2025-06-03	AGEN	0.00	12.46	15.47
2025-06-04	AGEN	0.00	12.46	15.47
2025-06-05	AGEN	0.00	12.46	15.47
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

-1.03

Avg. EPS Est. Current Quarter

-0.73

Avg. EPS Est. Next Quarter

-0.41

Insider Transactions

Institutional Transactions

12.46

Beta

1.42

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

96.1

Max Drawdown 5-Year %

-98.8

Target Price

11.5

P/E

Forward P/E

5.13

PEG

P/S

1.42

P/B

P/Free Cash Flow

EPS

-8.68

Average EPS Est. Cur. Y

-0.22

EPS Next Y. (Est.)

-2.76

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-191.72

Relative Volume

1.48

Return on Equity vs Sector %

31.8

Return on Equity vs Industry %

49.6

EPS 1 7Days Diff

5.4

EPS 1 30Days Diff

3.81

EBIT Estimation

90.2

Agenus Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 316

Agenus Inc., a clinical-stage biotechnology company, discovers and develops therapies to activate the body's immune system against cancer and infections in the United States and internationally. It offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops QS-21 Stimulon adjuvant, a saponin-based vaccine adjuvant. The company also develops Balstilimab, a programmed death receptor-1 (PD-1) blocking antibody; AGEN1181, a human Fc-enhanced cytotoxic T-lymphocyte antigen 4 (CTLA-4) blocking antibody that is in Phase 2 trials in metastatic colorectal cancer (mCRC), pancreatic cancer, and melanoma; AGEN2373, a CD137 monospecific antibody that is in Phase 1b clinical trial; AGEN1423, a CD73/TGFß TRAP antibody; AGEN1571, an ILT2 monospecific antibody that is in clinical development; and BMS-986442, a TIGIT bispecific antibodies. In addition, it develops INCAGN1876, a GITR agonist; INCAGN2390, a TIM-3 monoclonal antibodies; INCAGN2385, a LAG-3 monospecific antibody; MK-4830, a monospecific antibody targeting ILT4 that is in Phase 2 clinical trial; UGN-301, a zalifrelimab intravesical solution for the treatment of cancers of the urinary tract t; and AGEN1884. The company operates under the Agenus, MiNK, Prophage, Retrocyte Display, and STIMULON trademarks. It has collaborations with Bristol-Myers Squibb Company, Betta Pharmaceuticals Co., Ltd., UroGen Pharma Ltd., Gilead Sciences, Inc., Incyte Corporation, and Merck Sharp & Dohme. The company was formerly known as Antigenics Inc. and changed its name to Agenus Inc. in January 2011. Agenus Inc. was founded in 1994 and is headquartered in Lexington, Massachusetts.

stock quote shares AGEN – Agenus Inc. Stock Price stock today

news today AGEN – Agenus Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch AGEN – Agenus Inc. yahoo finance google finance

stock history AGEN – Agenus Inc. invest stock market

stock prices AGEN premarket after hours

ticker AGEN fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

AGEN – Agenus Inc.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: AGEN

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Get Started

About

Last Quarter Act. EPS

Average EPS Est. Cur. Y